PulmonaVat was founded with a deeply personal mission: to improve respiratory healthcare through ethical, human-relevant innovation.

PulmonaVat’s next-generation lung organoids are ethically developed from human cells, with the goal of replacing animal testing. Our models uniquely replicate adult lung tissue with complex morphology and function, offering a highly predictive and physiologically relevant platform for testing therapies with greater accuracy and translatability.